Search - tctmd.com

Displaying 21 - 40 of 60

Sort: Relevancy | Date

News Conference News TCT 2021

FAME 3: PCI Fails to Demonstrate Noninferiority to Surgery in Three-Vessel CAD

Michael O'Riordan

November 04, 2021

News Conference News ESC 2021

FFR During Angiogram Not Beneficial in Chest Pain Patients: RIPCORD 2

Michael O'Riordan

August 29, 2021

News Daily News

In ISCHEMIA, Stable CAD Treatment Effect Hinged on MI Definition

Michael O'Riordan

December 11, 2020

News Daily News

Plaque Burden, Not Coronary Stenosis, Linked to Future Events in Stable CAD

Michael O'Riordan

December 07, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2020

Caitlin E. Cox

August 28, 2020

News Conference News SCAI 2020

Intermediate Left Main Disease Linked to Worse Outcomes: ISCHEMIA

Caitlin E. Cox

May 20, 2020

News Conference News ACC 2020

More Symptoms, Less Extensive Disease in Women With Stable CAD: ISCHEMIA

Michael O'Riordan

March 28, 2020

News Opinion Editor's Corner

ISCHEMIA Questions? Some Answers From David Maron

Shelley Wood

December 09, 2019

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2019

Todd Neale

October 31, 2019

News

Analysis Hints at Survival Benefit With Revascularization in Stable Patients With Myocardial Ischemia

Michael O'Riordan

September 24, 2019

News Conference News EuroPCR 2019

Mortality Appears to Rise When SYNTAX II Score’s Advice for CABG Is Ignored: EXCEL Analysis

L.A. McKeown

June 07, 2019

News Daily News

FARGO: FFR No Help for CABG in Patients With Multivessel Disease

L.A. McKeown

November 27, 2018

News Conference News ESC 2018

New ESC/EACTS Revascularization Guidelines Make Room for Radial First, STICH, and DES for All

Michael O'Riordan

August 29, 2018

News Conference News EuroPCR 2018

‘Almost Perfect’ Agreement Seen Between Angiography- and CTA-Guided Treatment Decisions in Left Main, Three-Vessel Disease

Yael L. Maxwell

May 22, 2018

Presentation EuroPCR 2018

ORBITA: A Physiology-stratified Analysis of the Impact of FFR and iFR on Efficacy of Coronary Angioplasty in Stable Coronary Artery Disease

Presenter: Rasha Al-Lamee

May 22, 2018

News Daily News

CABG Bests PCI for 5-Year Survival in Biggest Analysis Yet, With Options for Left Main Disease

Yael L. Maxwell

March 08, 2018

News Conference News ACC 2018

ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last

Shelley Wood

March 05, 2018

News Daily News

Structural Valve Degeneration: VIVID Group Proposes New, Graduated Definition

Michael O'Riordan

January 26, 2018

News Conference News ACC 2017

iFR Matches FFR for Clinical Outcomes in Patients With Intermediate Lesions

Caitlin E. Cox

March 18, 2017

Presentation Stanford Coronary Physiology Conference 2016

Will FFR-Directed PCI Be Better Than CABG? Update on the FAME 3 trial

Presenter: William F. Fearon

October 28, 2016

Advertisement

FAME 3: PCI Fails to Demonstrate Noninferiority to Surgery in Three-Vessel CAD

FFR During Angiogram Not Beneficial in Chest Pain Patients: RIPCORD 2

In ISCHEMIA, Stable CAD Treatment Effect Hinged on MI Definition

Plaque Burden, Not Coronary Stenosis, Linked to Future Events in Stable CAD

TCTMD’s Top 10 Most Popular Stories for August 2020

Intermediate Left Main Disease Linked to Worse Outcomes: ISCHEMIA

More Symptoms, Less Extensive Disease in Women With Stable CAD: ISCHEMIA

ISCHEMIA Questions? Some Answers From David Maron

TCTMD’s Top 10 Most Popular Stories for October 2019

Analysis Hints at Survival Benefit With Revascularization in Stable Patients With Myocardial Ischemia

Mortality Appears to Rise When SYNTAX II Score’s Advice for CABG Is Ignored: EXCEL Analysis

FARGO: FFR No Help for CABG in Patients With Multivessel Disease

New ESC/EACTS Revascularization Guidelines Make Room for Radial First, STICH, and DES for All

‘Almost Perfect’ Agreement Seen Between Angiography- and CTA-Guided Treatment Decisions in Left Main, Three-Vessel Disease

ORBITA: A Physiology-stratified Analysis of the Impact of FFR and iFR on Efficacy of Coronary Angioplasty in Stable Coronary Artery Disease

CABG Bests PCI for 5-Year Survival in Biggest Analysis Yet, With Options for Left Main Disease

ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last

Structural Valve Degeneration: VIVID Group Proposes New, Graduated Definition

iFR Matches FFR for Clinical Outcomes in Patients With Intermediate Lesions

Will FFR-Directed PCI Be Better Than CABG? Update on the FAME 3 trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content